EP Biocomposites Board of Directors

Get the latest insights into the leadership at EP Biocomposites. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Rajkumar Gajanan Kamat Managing Director
Mr. Shreyas Dattatray Nadkarni Director
Ms. Leena Kamat Director
Mr. Nitin Anant Kunkolienker Independent Director
Mr. Dinesh Naguesh Shenoy Independent Director

EP Biocomposites Share price

EPBIO

136.9

9.60 (7.54%)
Last updated on 4 Sep, 2025 | 11:25 IST
BUYSELL
Today's High

136.90

Today's Low

129.90

52 Week Low

98.00

52 Week High

230.50

The current prices are delayed, login to your account for live prices

EP Biocomposites FAQs

The board at EP Biocomposites consists of experienced professionals, including Mr. Rajkumar Gajanan Kamat , Mr. Shreyas Dattatray Nadkarni , and others, overseeing the company’s strategic and corporate governance.

Directors at EP Biocomposites are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Rajkumar Gajanan Kamat is the current chairman at EP Biocomposites.

Executive directors at EP Biocomposites are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, EP Biocomposites adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At EP Biocomposites, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.